Transactions
HOOKIPA Pharma, Inc.’s asset sale to Gilead Sciences, Inc.
Date Announced:
05/22/2025
client:
HOOKIPA Pharma, Inc.
Status:
Pending
Value:
Undisclosed
Date Announced:
05/22/2025
client:
HOOKIPA Pharma, Inc.
Status:
Pending
Value:
Undisclosed
